Non‐Cyclical Mastalgia as a Central Sensitization Component: Implications for Multidisciplinary Treatment Approaches
Brain and Behavior · 2025-10 · 15 (10)
DOI: 10.1002/brb3.70962 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, online erschienen am 11.10.2025. Verfasst von Pelin Basım und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Medipol University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Central Nervous System Sensitization, Mastodynia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Non‐Cyclical mastalgia (NCM) is a chronic breast pain condition in women of reproductive age, often linked to anxiety and reduced quality of life (QoL). Evidence suggests central sensitization (CS) may contribute to NCM, but its clinical significance and management remain unclear.
Methods
This cross‐sectional study included 201 women aged 25 to 65, with 106 NCM patients and 95 healthy controls, to investigate the association between NCM and central sensitization syndromes (CSS). Data collection involved demographic characteristics and assessments using the Central Sensitization Inventory (CSI), Nottingham Health Profile (NHP), Short‐Form McGill Pain Questionnaire (SF‐MPQ), Pain Detect, Leeds Assessment of Neuropathic Symptoms and Signs (LANSS), and Hospital Anxiety and Depression Scale (HADS). The main outcome is to reveal the interrelationship between NCM and CSS.
Results
NCM patients had significantly higher Central Sensitization Inventory‐A (CSI‐A) scores than controls ( p < 0.001), with 15.1% surpassing the critical threshold of 40, indicating pronounced CS. NCM patients also had increased NHP‐1, NHP‐2, and HADS‐total scores ( p = 0.008, p = 0.003, p = 0.004), reflecting greater distress. Subgroup analyses showed more intense pain ( p < 0.001) and sleep disturbances ( p = 0.002). CSI‐A scores strongly correlated with SF‐MPQ, LANSS, Pain Detect, and HADS (all p < 0.001). Regression analysis identified pain duration, Pain Detect, and SF‐MPQ sensory scores as key predictors of CSI‐A ( p < 0.001).
Discussion
NCM shares characteristics with chronic pain syndromes linked to CSS. Multidisciplinary approaches and innovative treatments, such as cognitive therapies combined with integrative approaches may improve outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Medipol University, Istanbul, Turkey.
- Department of Physical Medicine and Rehabilitation, Medipol University, Istanbul, Turkey.
- Esenyurt Necmi Kadıoglu State Hospital, Department of General Surgery, Istanbul, Turkey.
- Department of General Surgery, Basaksehir State Hospital, Istanbul, Turkey.
ORCID-Profile: Pelin Basım
Zitieren
APA
Basım, P., Tolu, S., Pekuz, C. K., Abbasoglu, P., & Basım, S. (2025). Non‐Cyclical Mastalgia as a Central Sensitization Component: Implications for Multidisciplinary Treatment Approaches. Brain and Behavior, 15(10). https://doi.org/10.1002/brb3.70962
Vancouver
Basım P, Tolu S, Pekuz CK, Abbasoglu P, Basım S. Non‐Cyclical Mastalgia as a Central Sensitization Component: Implications for Multidisciplinary Treatment Approaches. Brain and Behavior. 2025;15(10). doi:10.1002/brb3.70962
BibTeX
@article{Basm2025,
author = {Basım, Pelin and Tolu, Sena and Pekuz, Caglar Kazim and Abbasoglu, Perya and Basım, Serdar},
title = {Non‐Cyclical Mastalgia as a Central Sensitization Component: Implications for Multidisciplinary Treatment Approaches},
journal = {Brain and Behavior},
year = {2025},
volume = {15},
number = {10},
doi = {10.1002/brb3.70962}
}
EUVIMED